First Trust Advisors’s TherapeuticsMD TXMD Stock Holding History

First Trust Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,032	Closed	-$143K	–	2591
2021 Q4	$143K	Buy	8,032 +687	+9%	+$20.6K	﹤0.01%	2486
2021 Q3	$272K	Buy	7,345 +3,975	+118%	+$176K	﹤0.01%	2402
2021 Q2	$201K	Sell	3,370 -38	-1%	-$2.3K	﹤0.01%	2426
2021 Q1	$228K	Buy	+3,408	New	+$267K	﹤0.01%	2359
2019 Q1	–	Sell	-2,905	Closed	-$553K	–	2454
2018 Q4	$553K	Sell	2,905 -567	-16%	-$138K	﹤0.01%	2095
2018 Q3	$1.14M	Buy	+3,472	New	+$1.06M	﹤0.01%	1913
2018 Q2	–	Sell	-1,893	Closed	-$461K	–	2481
2018 Q1	$461K	Buy	+1,893	New	+$531K	﹤0.01%	2047
2016 Q4	–	Sell	-1,814	Closed	-$618K	–	2506
2016 Q3	$618K	Buy	1,814 +774	+74%	+$283K	﹤0.01%	1924
2016 Q2	$442K	Buy	+1,040	New	+$429K	﹤0.01%	1987

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

First Trust Advisors's TXMD Position: Q1 2022 in Review

First Trust Advisors sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 8,032 shares — an estimated $143K sold.

First Trust Advisors first reported a position in TXMD in Q2 2016 and held it in 9 quarters. The position peaked at $1.14M in Q3 2018. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

First Trust Advisors reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
First Trust Advisors sold 8,032 TherapeuticsMD shares in Q1 2022, an estimated $143K.
First Trust Advisors first reported a position in TherapeuticsMD in Q2 2016 and held it in 9 quarters.
First Trust Advisors's TherapeuticsMD position peaked at $1.14M in Q3 2018.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on First Trust Advisors's 13F filing for Q1 2022, filed 13 May 2022.